Fortisᴺ Partners

Fortisᴺ Partners is a private capital partnership that is raising $500mm USD for the sake of bringing speed to science. Our premise is to speed up the clinical science process for the sake of saving lives by collapsing drug development timelines. We believe that the best way to do this is through innovation and technology. We invest in companies that directly impact and collapse the drug development cycle. Following the Transcelerate principles and guidelines, our framework ensures that we are focused on investing in growth stage. Furthermore, we are focused on innovative technology companies that collapse recruiting timelines, increase patient engagement, promote physician engagement, and effectively collect and process data more efficiently than ever. The name of the fund is the Nightingale Fund.